Q: Hi Peter and Team,
This is the first question for this Middlefield ETF. I realize that its MER is quite high, but its performance appears to be above its peers. I am also impressed with its 5.085% distribution yield and its very low Beta of 0.34.
Portfolio Analytics indicates that we’re too low in the Healthcare sector as well as US holdings. This ETF could reduce the imbalance.
What is your opinion on MHCD at this time? Are there other ETFs in this sector that you find more compelling?
Thanks as always for your valued insight.
This is the first question for this Middlefield ETF. I realize that its MER is quite high, but its performance appears to be above its peers. I am also impressed with its 5.085% distribution yield and its very low Beta of 0.34.
Portfolio Analytics indicates that we’re too low in the Healthcare sector as well as US holdings. This ETF could reduce the imbalance.
What is your opinion on MHCD at this time? Are there other ETFs in this sector that you find more compelling?
Thanks as always for your valued insight.
5i Research Answer:
MHCD We would consider it a decent fund. Assets $149M, YTD 10.02%, 5-year 6.99%, yield 5.10%, assets $148M. It has 44 securities, mostly large, well-known pharmas. The largest position is 7.3% (LLY). It is certainly on the lower end of the volatility scale. The US is 76% of the fund. There are some other more global funds available, but none really show the same (low) volatility, or they have not-as-good performance, or have lower yields. For a Canadian listed ETF we would consider MHCD a good choice.